Department of Medical Ultrasound, The Second Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China.
Department of Medical Ultrasound, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei Province, China.
World J Gastroenterol. 2022 Jul 21;28(27):3398-3409. doi: 10.3748/wjg.v28.i27.3398.
Artificial intelligence (AI) is playing an increasingly important role in medicine, especially in the field of medical imaging. It can be used to diagnose diseases and predict certain statuses and possible events that may happen. Recently, more and more studies have confirmed the value of AI based on ultrasound in the evaluation of diffuse liver diseases and focal liver lesions. It can assess the severity of liver fibrosis and nonalcoholic fatty liver, differentially diagnose benign and malignant liver lesions, distinguish primary from secondary liver cancers, predict the curative effect of liver cancer treatment and recurrence after treatment, and predict microvascular invasion in hepatocellular carcinoma. The findings from these studies have great clinical application potential in the near future. The purpose of this review is to comprehensively introduce the current status and future perspectives of AI in liver ultrasound.
人工智能(AI)在医学领域,尤其是在医学影像领域,正发挥着越来越重要的作用。它可以用于诊断疾病,预测某些状态和可能发生的事件。最近,越来越多的研究证实了基于超声的 AI 在评估弥漫性肝脏疾病和局灶性肝脏病变中的价值。它可以评估肝纤维化和非酒精性脂肪肝的严重程度,鉴别良恶性肝脏病变,区分原发性和继发性肝癌,预测肝癌治疗效果和治疗后复发,预测肝细胞癌的微血管侵犯。这些研究结果在不久的将来具有很大的临床应用潜力。本综述的目的是全面介绍 AI 在肝脏超声中的现状和未来展望。